Title:
PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
Document Type and Number:
WIPO Patent Application WO2003053366
Kind Code:
A3
Abstract:
The subject invention provides compounds having the structure:, wherein R1 is substituted or unsubstituted phenyl or a 5-6 membered heterocyclic or heteroaromatic ring containing from 1 to 5 heteroatoms; R2 is hydrogen, or a substituted or unsubstituted alkyl, -C(O)-alkyl, -C(O)-O-alkyl, alkoxy, cycloalkyl, alkenyl, monocyclic or bicyclic aryl, heteroaryl or heterocyclic moiety; R3 is hydrogen, or a substituted or unsubstituted alkyl, -C(O)-alkyl, -C(O)-O-alkyl, alkoxy, cycloalkyl, alkenyl, monocyclic or bicyclic aryl, heteroaryl or heterocyclic moiety, or R2 and R3 are joined to form a heterocyclic ring; wherein the dashed line represents a second bond which may be present or absent, and when present R3 is oxygen; R4 and R5 are each independently substituted or unsubstituted alkyl, -C(O)-alkyl, -C(O)-O-alkyl, alkoxy, cycloalkyl, alkenyl, monocyclic or bicyclic aryl, heteroaryl or heterocyclic moiety, or R4NR5 together form a substituted or unsubstituted monocyclic or bicyclic, heterocyclic or heteroaryl moiety containing from 1 to 6 heteroatoms; R12 is hydrogen, alkyl, halogen or cyano; and n is 0, 1, 2, 3 or 4, or an enantiomer, or a specific tautomer, or a pharmaceutically acceptable salt thereof and a method for treating a disease associated with the A2b adenosine receptor by administering a therapeutically effective amount of the compounds of the invention.
Inventors:
CASTELHANO ARLINDO (US)
MCKIBBEN BRYAN (US)
STEINIG ARNO (US)
COLLINGTON ERIC WILLIAM (GB)
MCKIBBEN BRYAN (US)
STEINIG ARNO (US)
COLLINGTON ERIC WILLIAM (GB)
Application Number:
PCT/US2002/041273
Publication Date:
January 29, 2004
Filing Date:
December 20, 2002
Export Citation:
Assignee:
OSI PHARM INC (US)
CASTELHANO ARLINDO (US)
MCKIBBEN BRYAN (US)
STEINIG ARNO (US)
COLLINGTON ERIC WILLIAM (GB)
CASTELHANO ARLINDO (US)
MCKIBBEN BRYAN (US)
STEINIG ARNO (US)
COLLINGTON ERIC WILLIAM (GB)
International Classes:
A61K31/506; A61K31/513; A61K31/519; A61K31/5377; A61K31/55; A61K31/551; A61P1/00; A61P1/12; A61P3/10; A61P9/00; A61P9/10; C07D243/08; A61P9/12; A61P11/06; A61P17/00; A61P17/04; A61P19/02; A61P27/02; A61P35/00; A61P37/08; A61P43/00; C07D239/42; C07D239/48; C07D401/12; C07D401/14; C07D403/12; C07D405/12; C07D405/14; C07D409/12; C07D409/14; C07D411/12; C07D413/12; C07D417/12; C07D471/10; C07D487/04; (IPC1-7): A61K31/495; A61K31/50; A61K31/505; A61K31/535; A61K31/55; A61P9/00; C07D239/02; C07D243/08; C07D403/00; C07D413/00; C07D473/00
Domestic Patent References:
WO1999064407A1 | 1999-12-16 |
Other References:
See also references of EP 1465631A4
Download PDF:
Previous Patent: SYN3 COMPOSITIONS AND METHODS
Next Patent: HYDROGENATION OF PRECURSORS TO THIAZOLIDINEDIONE ANTIHYPERGLYCEMICS
Next Patent: HYDROGENATION OF PRECURSORS TO THIAZOLIDINEDIONE ANTIHYPERGLYCEMICS